.jpg?format=webp&width=780)
The study aims to elucidate the pathogenesis and heterogeneity of patients with Behçet's syndrome (BS) involving different organs using in‐depth proteomics and identify the biomarkers for clinical assessment and treatment of patients. The BS group had 220 differentially expressed proteins, which discriminate 88.6% of the patients and 95.5% of the HCs. The results provide valuable insight into the pathogenesis of organ‐resolved BS in terms of proteomic characteristics and potential biomarkers for vascular BS clinical assessment and treatment in the future.
Like
Save
Share